{
  "paper_metadata": {
    "pmid": "36577523",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on a somatic BRCA2 pathogenic variant from a case report involving a patient with metastatic lung adenocarcinoma."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1411G>T",
      "protein_notation": "p.Glu471Ter",
      "genomic_position": "Chr 13:32907026",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "64-year-old male, Chinese",
        "phenotype": "metastatic lung adenocarcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 64,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "metastatic lung adenocarcinoma with a somatic BRCA2 pathogenic variant",
          "evidence_sentence": "In May 2020, next-generation sequencing (NGS) (Oncomine Comprehensive Assay v3) was conducted on the lung biopsy, which revealed a somatic BRCA2 c.1411G > T (p.Glu471Ter) pathogenic variant."
        }
      ],
      "functional_data": {
        "summary": "The variant is predicted to result in an amino acid substitution of glutamic acid with a stop codon, causing a nonsense variant that leads to loss of normal protein function.",
        "assays": [
          "Next-generation sequencing (NGS)"
        ]
      },
      "segregation_data": "Not applicable; only one patient reported.",
      "population_frequency": "Not provided.",
      "evidence_level": "Strong evidence for pathogenicity based on loss-of-function effects.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The patient had a germline BRCA2 wild type.",
      "key_quotes": [
        "Loss-of-function variants in BRCA2 are known to be pathogenic.",
        "The absence of BRCA2 leads to defective DNA double-strand break repair by homologous recombination."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the BRCA2 variant was extracted from the main text."
  }
}